[Skip to Content]
[Skip to Content Landing]

August 2019 - April 2016

Decade

Year

Issue

November 2018, Vol 3, No. 11, Pages 1029-1136

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2018;3(11):1029. doi:10.1001/jamacardio.2017.3391
Original Investigation

Association of Same-Day Discharge After Elective Percutaneous Coronary Intervention in the United States With Costs and Outcomes

Abstract Full Text
open access
JAMA Cardiol. 2018;3(11):1041-1049. doi:10.1001/jamacardio.2018.3029

This cohort study examines the incidence, trends, and hospital variation in same-day discharge and its association with readmissions for bleeding, acute kidney injury, acute myocardial infarction, or mortality in the United States.

Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis

Abstract Full Text
JAMA Cardiol. 2018;3(11):1050-1059. doi:10.1001/jamacardio.2018.3551

This meta-analysis compares the efficacy and safety of drug-eluting stents optimized for biocompatibility vs bare-metal stents with a single month of dual antiplatelet therapy.

Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics

Abstract Full Text
open access has active quiz
JAMA Cardiol. 2018;3(11):1060-1068. doi:10.1001/jamacardio.2018.3152

This study determines the clinical outcomes of patients with asymptomatic aortic stenosis using data from the Heart Valve Clinic International Database.

Association Between Hospital Surgical Aortic Valve Replacement Volume and Transcatheter Aortic Valve Replacement Outcomes

Abstract Full Text
JAMA Cardiol. 2018;3(11):1070-1078. doi:10.1001/jamacardio.2018.3562

This cohort study examines the association of surgical aortic valve replacement with patient outcomes of transcatheter aortic valve replacement procedures performed within 1 year, 2 years, and for the entire period after initiation of transcatheter aortic valve replacement programs.

Association of Weather With Day-to-Day Incidence of Myocardial Infarction: A SWEDEHEART Nationwide Observational Study

Abstract Full Text
JAMA Cardiol. 2018;3(11):1081-1089. doi:10.1001/jamacardio.2018.3466

This population-based study investigates whether weather is associated with day-to-day incidence of myocardial infarction in Sweden.

A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention

Abstract Full Text
JAMA Cardiol. 2018;3(11):1090-1095. doi:10.1001/jamacardio.2018.3476

This cross-sectional study uses National Health and Nutrition Survey data to model a 10-year risk, 10-year benefit, and 30-year benefit approach to selecting individuals for statin therapy.

Brief Report

Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models

Abstract Full Text
JAMA Cardiol. 2018;3(11):1096-1100. doi:10.1001/jamacardio.2018.2763

This observational study determines whether long-term cumulative systolic blood pressure in the risk equations improves the predictive ability compared with single systolic blood pressure measurements.

Association of Unrecognized Myocardial Infarction With Long-term Outcomes in Community-Dwelling Older Adults: The ICELAND MI Study

Abstract Full Text
JAMA Cardiol. 2018;3(11):1101-1106. doi:10.1001/jamacardio.2018.3285

This cohort study of community-dwelling, elderly individuals in Iceland examines the association of unrecognized myocardial infarction by cardiovascular magnetic resonance imaging with major adverse cardiac events, such as death, nonfatal myocardial infarction, and heart failure.

Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction

Abstract Full Text
open access
JAMA Cardiol. 2018;3(11):1108-1112. doi:10.1001/jamacardio.2018.3368

This cohort study compares the efficacy of a novel point-of-care troponin assay with an established assay in patients with possible acute myocardial infarction.

Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial

Abstract Full Text
JAMA Cardiol. 2018;3(11):1113-1118. doi:10.1001/jamacardio.2018.3408

This secondary analysis of a randomized clinical trial investigates whether periprocedural loading doses of atorvastatin are associated with decreased 30-day major adverse cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Pregnancy Outcomes in Women With Transposition of the Great Arteries After an Arterial Switch Operation

Abstract Full Text
JAMA Cardiol. 2018;3(11):1119-1122. doi:10.1001/jamacardio.2018.2747

This cohort study seeks to determine the outcomes of pregnancy in women with transposition of the great arteries after an arterial switch operation, as well as outcomes of their offspring.

Viewpoint

Patenting Laws of Nature: Effect on Cardiovascular Innovation

Abstract Full Text
JAMA Cardiol. 2018;3(11):1031-1032. doi:10.1001/jamacardio.2018.3365

This Viewpoint discusses the importance of clearer patent laws for innovation in cardiovascular science.

Clinical and Genetic Complexities of Left Ventricular Noncompaction: Preventing Overdiagnosis in a Disease We Do Not Understand

Abstract Full Text
JAMA Cardiol. 2018;3(11):1033-1034. doi:10.1001/jamacardio.2018.2465

This Viewpoint describes deficits in knowledge of the genetics, environment, and comorbidities in the development and outcomes of left ventricular noncompaction.

The Evolution of Patient-Reported Outcomes in Clinical Trials and Management of Patients With Coronary Artery Disease: 20 Years With the Seattle Angina Questionnaire

Abstract Full Text
JAMA Cardiol. 2018;3(11):1035-1036. doi:10.1001/jamacardio.2018.2849

This Viewpoint presents the background, implementation, and prospective uses of the Seattle Angina Questionnaire 20 years after its creation.

From the Heart

Risks, Benefits, and What Matters to the Patient

Abstract Full Text
JAMA Cardiol. 2018;3(11):1038. doi:10.1001/jamacardio.2018.2906

This personal essay recounts an example of the complexities of informed consent.

Editorial

The Myths of the Bare-Metal Stent

Abstract Full Text
JAMA Cardiol. 2018;3(11):1039-1040. doi:10.1001/jamacardio.2018.3573
Invited Commentary

10 000 Hours—Is Prior Experience in Cardiac Surgery Enough?

Abstract Full Text
JAMA Cardiol. 2018;3(11):1078-1080. doi:10.1001/jamacardio.2018.3657
JAMA Cardiology Clinical Challenge

Dyspnea and Edema in a Woman With Antiphospholipid Syndrome

Abstract Full Text
has active quiz has multimedia
JAMA Cardiol. 2018;3(11):1123-1124. doi:10.1001/jamacardio.2018.1704

A woman in her 50s with a history of rheumatic heart disease with mechanical mitral and tricuspid valve replacements presented to the hospital with 1 week of shortness of breath and fatigue; transthoracic echocardiogram showed no pericardial effusion, normal left ventricular systolic function, a well-seated mitral valve prosthesis with normal gradients, a dilated and diffusely hypokinetic right ventricle, and an elevated mean tricuspid valve gradient. What would you do next?

Comment & Response

Can Stroke Complications Be Distinguished From Comorbid Stroke in Administrative Data?

Abstract Full Text
JAMA Cardiol. 2018;3(11):1126. doi:10.1001/jamacardio.2018.2903

Public Reporting of Percutaneous Coronary Intervention Outcomes Done Differently—Leading From Washington

Abstract Full Text
JAMA Cardiol. 2018;3(11):1126-1127. doi:10.1001/jamacardio.2018.3000

Public Reporting of Percutaneous Coronary Intervention Outcomes Done Differently—Leading From Washington—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(11):1127-1128. doi:10.1001/jamacardio.2018.3010

Optimizing the Detection of Left Ventricular Thrombus Following Acute Myocardial Infarction in the Current Era

Abstract Full Text
JAMA Cardiol. 2018;3(11):1128-1129. doi:10.1001/jamacardio.2018.3136

Optimizing the Detection of Left Ventricular Thrombus Following Acute Myocardial Infarction in the Current Era—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(11):1129. doi:10.1001/jamacardio.2018.3142

Ensuring Optimal Adjustment for Determinations of Institutional Quality

Abstract Full Text
JAMA Cardiol. 2018;3(11):1129-1130. doi:10.1001/jamacardio.2018.3256

Ensuring Optimal Adjustment for Determinations of Institutional Quality—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(11):1130-1131. doi:10.1001/jamacardio.2018.3259
Editor's Note

The Importance of Listening to Patients: The Seattle Angina Questionnaire

Abstract Full Text
JAMA Cardiol. 2018;3(11):1037. doi:10.1001/jamacardio.2018.2861

Is There Any Current Role for Bare-Metal Coronary Stents?

Abstract Full Text
JAMA Cardiol. 2018;3(11):1059. doi:10.1001/jamacardio.2018.3660

Thresholds for Valve Replacement in Asymptomatic Patients With Aortic Stenosis

Abstract Full Text
JAMA Cardiol. 2018;3(11):1068-1069. doi:10.1001/jamacardio.2018.3277

Unrecognized Myocardial Infarction and Unrecognized Cardiovascular Risk

Abstract Full Text
JAMA Cardiol. 2018;3(11):1106-1107. doi:10.1001/jamacardio.2018.3374
Correction

Errors in Abstract, Figure 1, Table, Conclusion, and Author Contributions

Abstract Full Text
free access
JAMA Cardiol. 2018;3(11):1131. doi:10.1001/jamacardio.2018.3778
JAMA Cardiology Patient Page

Should I Participate in a Cardiac Rehabilitation Program?

Abstract Full Text
free access
JAMA Cardiol. 2018;3(11):1136. doi:10.1001/jamacardio.2018.3252

This Patient Page describes candidates for cardiac rehabilitation and how it can help treat cardiovascular disease.

JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2018;3(11):1030. doi:10.1001/jamacardio.2017.3392
×